Avista Healthcare Partners and Damier Group have agreed to acquire Sanotact Group, a Germany-based vitamins, minerals and supplements (“VMS”) platform, from existing shareholder FLOTTE.
The transaction will see FLOTTE make a significant reinvestment in the business following closing. Avista said the acquisition marks its ninth platform investment in the consumer healthcare sector and reflects its continued focus on businesses benefiting from long-term preventative health and self-care trends. Sanotact Group develops, manufactures and commercializes VMS products through a diversified business model that combines a scaled CDMO platform with a portfolio of branded consumer health products, including the Sanotact brand. The company offers capabilities across major VMS dosage forms and serves drugstore and distribution customers across approximately 80 international markets.
Alantra acted as M&A advisor to FLOTTE, with CMS serving as legal counsel. White & Caseadvised Avista and Damier on the transaction.